Last $7.74 USD
Change Today -0.15 / -1.90%
Volume 711.4K
As of 5:20 PM 02/26/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Edward W. Frykman

Director, Chairman of Audit Committee, Member of Nomination Committee, Member of Compensation Committee, Director of Insert Therapeutics Inc, Director of Unidym, Director of Aonex and Director of Calando, Arrowhead Research Corp.
AgeTotal Calculated CompensationThis person is connected to 34 board members in 4 different organizations across 5 different industries.

See Board Relationships
78$261,225

Background*

Mr. Edward W. Frykman has been an Account Executive of Crowell, Weedon & Co. since 1992. Mr. Frykman served as a Senior Vice President of L.H. Friend & Co. In addition, he served as a Senior Account Executive of Shearson Lehman Hutton, where he served as Manager of the Los Angeles Regional Retail Office at E. F. Hutton & Co. He serves as a Director of Unidym, Inc., Insert Therapeutics Inc., Calando Pharmaceuticals Inc. and Aonex. Mr. Frykman has been a Director of Acacia ...

Read Full Background

Corporate Headquarters*

225 South Lake Avenue
Pasadena, California 91101

United States

Phone: 626-304-3400
Fax: 626-304-3401

Board Members Memberships*

Director
Former Director, Chairman of Audit Committee, Chairman of Compensation Committee and Chairman of Nomination/Governance Committee
Director
1996-N/A
Former Director, Member of Audit Committee, Member of Compensation Committee and Member of Nominating & Governance Committee
1996-Present
Director, Member of Audit Committee, Member of Compensation Committee and Member of Nominating & Governance Committee
2004-Present
Director, Chairman of Audit Committee, Member of Nomination Committee, Member of Compensation Committee, Director of Insert Therapeutics Inc, Director of Unidym, Director of Aonex and Director of Calando

Education*

BSBA
University of Florida

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$43,125
Total Calculated Compensation$261,225
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ARWR:US $7.74 USD -0.15

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ARROWHEAD RESEARCH CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.